Skip to content

HYG vs JNK: returns, risk and drawdowns compared

iShares iBoxx $ High Yield Corporate Bond ETF against SPDR Bloomberg High Yield Bond ETF, over the same 18 years (January 2008 to October 2026) with dividends reinvested.

Data updated October 2026

HYG

iShares iBoxx $ High Yield Corporate Bond ETF

10,000 became

24,404

A year on average
+4.9%
Annual volatility
10.2%
Deepest fall
−29.8%
Worst month
−11.5%

JNK

SPDR Bloomberg High Yield Bond ETF

10,000 became

139,951

A year on average
+15.0%
Annual volatility
12.4%
Deepest fall
−27.4%
Worst month
−17.6%

JNK came out ahead by 10.2 percentage points a year from January 2008 to October 2026. JNK swung more (12.4% against 10.2% a year). The correlation of monthly returns was 0.94: they moved almost in lockstep.

Growth of 10,000: HYG vs JNK

050k100k150k200820152022
HYG — iShares iBoxx $ High Yield Corporate Bond ETFJNK — SPDR Bloomberg High Yield Bond ETF

Who was ahead, and when

The gap between the two over the previous three years, at each month-end. Above zero HYG had returned more, below zero JNK. HYG was ahead in 15% of the 191 three-year periods.

−20 pt0200920152021

Annualised 3-year return of HYG minus that of JNK, in percentage points a year.

Falls from the previous high

-20%0%200820152022
HYGJNK

Month-end values. Deepest fall: HYG −29.8%, JNK −27.4%.

All the figures

HYGJNK
Annual return (CAGR)+4.9%+15.0%
Total return+144%+1300%
Annual volatility10.2%12.4%
Deepest fall (month-end)−29.8%−27.4%
Worst month−11.5%−17.6%
Best month+16.8%+23.1%
Positive months65%72%
Best year2009: +28.5%2009: +81.8%
Worst year2008: −17.6%2022: −12.2%
1-year return+1.1%+1.3%
5 years, a year+3.2%+3.1%
10 years, a year+4.1%+7.2%
Trading currencyUSDUSD

First nine rows: the same 226 months for both funds. Trailing returns: to each fund’s last close.

Year by year

2025
HYG+8.6%
JNK+8.8%
2024
HYG+8.0%
JNK+7.7%
2023
HYG+11.6%
JNK+12.4%
2022
HYG−11.0%
JNK−12.2%
2021
HYG+3.8%
JNK+4.0%
2020
HYG+4.0%
JNK+4.5%
2019
HYG+14.1%
JNK+19.2%
2018
HYG−2.0%
JNK+8.2%
2017
HYG+6.1%
JNK+19.1%
2016
HYG+13.4%
JNK+29.8%
2015
HYG−5.0%
JNK+5.1%
2014
HYG+1.9%
JNK+13.0%
2013
HYG+5.8%
JNK+19.6%
2012
HYG+11.7%
JNK+30.5%
2011
HYG+6.8%
JNK+24.0%
2010
HYG+11.9%
JNK+42.9%
2009
HYG+28.5%
JNK+81.8%
2008
HYG−17.6%
JNK−6.5%

Full calendar years both funds were trading. The higher of the two each year is in bold.

Holding both: half HYG, half JNK

HYG aloneJNK alone50/50
A year on average+4.9%+15.0%+9.9%
Annual volatility10.2%12.4%11.1%
Deepest fall (month-end)−29.8%−27.4%−28.3%
Worst month−11.5%−17.6%−14.5%

With a correlation of 0.94 the mix behaved almost like either fund alone: its volatility of 11.1% sits between the two. Rebalanced to 50/50 every month, before costs.

Questions

Which has returned more, HYG or JNK?

From January 2008 to October 2026, HYG returned +4.9% a year and JNK +15.0% a year, with dividends reinvested. Over rolling 3-year periods HYG did better in 15% of cases. Past returns do not predict future returns.

Which is riskier, HYG or JNK?

Over the same months annual volatility was 10.2% for HYG and 12.4% for JNK; the deepest fall from a month-end high was 29.8% and 27.4%, and the worst single month −11.5% and −17.6%.

How correlated are HYG and JNK?

The correlation of their monthly returns was 0.94: they moved almost in lockstep. Holding both adds little diversification compared with holding one.

What about holding both HYG and JNK?

Half in each, rebalanced every month, returned +9.9% a year over the same period, with 11.1% annual volatility and a deepest month-end fall of 28.3%.

More comparisons

How the figures are calculated

Total return in the fund’s trading currency, from end-of-day prices with dividends reinvested on the ex-date. The fund’s own ongoing charges are already reflected in its price; trading costs, taxes and currency conversion are not included. Past returns do not predict future returns.

The comparison uses only the months in which both funds have prices, so the figures cover the same period even when one fund is older.

Source: MarketStack end-of-day prices, total return with dividends reinvested. Figures are historical and descriptive; they are not forecasts and not investment advice. MEDGE Capital does not recommend buying or selling any instrument. Risk disclaimer.